Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for JNJ, sign up here.
Income Statement
Revenue
$85.2bn
Gross Profit
$58.6bn
Earning before Tax
$36.9bn
Net Income
$35.2bn
Net Income Common Shareholders
$35.2bn
EPS
13.88
Balance Sheet
Cash
$21.9bn
Debt
$29.3bn
Assets
$167.6bn
Liabilities
$98.8bn
Equity
$68.8bn
Enterprise Value
$387.5bn
Cash Flow Statement
Net Cash from Operations
$22.8bn
Net Cash from Investing
$878.0m
Net Cash from Financing
$-15.8bn
Net Cash Flow
$7.7bn
Free Cash Flow
$18.2bn
Free Cash Flow per Share
$7.20
Metrics
Price to Equity
10.73
Price to Equity (Damodaran)
11.29
Price to Book
5.49
Net Margin
0.41
Return on Equity
0.49
Return on Sales
0.44
Get immediate access to 5-years of reference grade data for JNJ for free.
Sign upJohnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company''s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Company Info
Industry
Drug Manufacturers - General
Employees
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
Phone
732 524 0400
Website
Last Updated
2024-02-19
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.